14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.80 $2.41 Monday, 4th Mar 2024 GERN stock ended at $2.08. This is 7.96% less than the trading day before Friday, 1st Mar 2024. During the day the stock fluctuated 10.06% from a day low at $2.07 to a day high of $2.28.
90 days $1.80 $2.41
52 weeks $1.68 $3.74

Historical Geron Corporation prices

Date Open High Low Close Volume
2024-03-04 $2.26 $2.28 $2.07 $2.08 8 091 479
2024-03-01 $2.03 $2.30 $2.02 $2.26 13 440 920
2024-02-29 $2.02 $2.20 $2.00 $2.00 9 247 699
2024-02-28 $2.10 $2.32 $1.94 $1.95 13 380 785
2024-02-27 $2.10 $2.14 $2.05 $2.07 11 045 896
2024-02-26 $1.99 $2.09 $1.98 $2.07 8 766 480
2024-02-23 $1.97 $2.00 $1.94 $1.96 3 690 781
2024-02-22 $1.96 $1.99 $1.91 $1.97 5 537 951
2024-02-21 $1.95 $2.00 $1.91 $1.93 5 336 138
2024-02-20 $2.02 $2.08 $1.92 $1.95 7 978 024
2024-02-16 $2.09 $2.09 $2.00 $2.01 6 336 660
2024-02-15 $2.11 $2.14 $2.07 $2.09 6 727 346
2024-02-14 $2.20 $2.22 $2.08 $2.10 7 843 153
2024-02-13 $2.30 $2.34 $2.07 $2.07 11 154 352
2024-02-12 $2.10 $2.41 $2.10 $2.37 18 667 491
2024-02-09 $1.92 $2.12 $1.92 $2.11 8 307 134
2024-02-08 $1.90 $1.93 $1.87 $1.91 4 352 144
2024-02-07 $1.90 $1.92 $1.83 $1.89 4 251 922
2024-02-06 $1.82 $1.92 $1.80 $1.89 5 976 340
2024-02-05 $1.87 $1.90 $1.81 $1.82 6 326 511
2024-02-02 $1.90 $1.91 $1.82 $1.83 7 529 784
2024-02-01 $1.91 $1.97 $1.85 $1.92 10 695 154
2024-01-31 $2.03 $2.03 $1.84 $1.84 11 716 794
2024-01-30 $2.07 $2.12 $2.00 $2.01 10 247 613
2024-01-29 $2.17 $2.17 $2.02 $2.11 7 715 992
Click to get the best stock tips daily for free!

About Geron Corporation

Geron Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes a... GERN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT